Trust Company of Vermont’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-145
| Closed | -$1.67K | – | 1112 |
|
|
2025
Q2 | $1.67K | Hold |
145
| – | – | ﹤0.01% | 1015 |
|
|
2025
Q1 | $2.17K | Hold |
145
| – | – | ﹤0.01% | 934 |
|
|
2024
Q4 | $2.51K | Hold |
145
| – | – | ﹤0.01% | 941 |
|
|
2024
Q3 | $2.69K | Buy |
+145
| New | +$2.91K | ﹤0.01% | 931 |
|
|
2020
Q2 | – | Sell |
-250
| Closed | -$3K | – | 773 |
|
|
2020
Q1 | $3K | Hold |
250
| – | – | ﹤0.01% | 788 |
|
|
2019
Q4 | $9K | Hold |
250
| – | – | ﹤0.01% | 719 |
|
|
2019
Q3 | $12K | Sell |
250
-12
| -5% | -$558 | ﹤0.01% | 714 |
|
|
2019
Q2 | $14K | Buy |
262
+12
| +5% | +$704 | ﹤0.01% | 688 |
|
|
2019
Q1 | $17K | Hold |
250
| – | – | ﹤0.01% | 627 |
|
|
2018
Q4 | $15K | Hold |
250
| – | – | ﹤0.01% | 664 |
|
|
2018
Q3 | $29K | Hold |
250
| – | – | ﹤0.01% | 614 |
|
|
2018
Q2 | $32K | Hold |
250
| – | – | ﹤0.01% | 601 |
|
|
2018
Q1 | $27K | Hold |
250
| – | – | ﹤0.01% | 599 |
|
|
2017
Q4 | $27K | Hold |
250
| – | – | ﹤0.01% | 610 |
|
|
2017
Q3 | $25K | Hold |
250
| – | – | ﹤0.01% | 602 |
|
|
2017
Q2 | $25K | Hold |
250
| – | – | ﹤0.01% | 609 |
|
|
2017
Q1 | $29K | Hold |
250
| – | – | ﹤0.01% | 558 |
|
|
2016
Q4 | $30K | Hold |
250
| – | – | ﹤0.01% | 547 |
|
|
2016
Q3 | $28K | Sell |
250
-100
| -29% | -$11.5K | ﹤0.01% | 512 |
|
|
2016
Q2 | $43K | Hold |
350
| – | – | 0.01% | 405 |
|
|
2016
Q1 | $39K | Sell |
350
-20
| -5% | -$2.08K | 0.01% | 422 |
|
|
2015
Q4 | $40K | Buy |
370
+20
| +6% | +$2.29K | 0.01% | 419 |
|
|
2015
Q3 | $35K | Hold |
350
| – | – | 0.01% | 443 |
|
|
2015
Q2 | $40K | Hold |
350
| – | – | 0.01% | 436 |
|
|
2015
Q1 | $36K | Hold |
350
| – | – | 0.01% | 442 |
|
|
2014
Q4 | $42K | Hold |
350
| – | – | 0.01% | 421 |
|
|
2014
Q3 | $52K | Hold |
350
| – | – | 0.01% | 386 |
|
|
2014
Q2 | $59K | Sell |
350
-50
| -13% | -$8.89K | 0.01% | 354 |
|
|
2014
Q1 | $80K | Hold |
400
| – | – | 0.01% | 310 |
|
|
2013
Q4 | $76K | Hold |
400
| – | – | 0.01% | 305 |
|
|
2013
Q3 | $68K | Hold |
400
| – | – | 0.01% | 304 |
|
|
2013
Q2 | $60K | Buy |
+400
| New | +$56.7K | 0.01% | 309 |
|
Other funds holding CLB
AI
DGI
Trust Company of Vermont's CLB Position: Q3 2025 in Review
Trust Company of Vermont sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 145 shares — an estimated $1.67K sold.
Trust Company of Vermont first reported a position in CLB in Q2 2013 and held it in 32 quarters. The position peaked at $80K in Q1 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.
- Trust Company of Vermont reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
- Trust Company of Vermont sold 145 Core Laboratories shares in Q3 2025, an estimated $1.67K.
- Trust Company of Vermont first reported a position in Core Laboratories in Q2 2013 and held it in 32 quarters.
- Trust Company of Vermont's Core Laboratories position peaked at $80K in Q1 2014.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.
Based on Trust Company of Vermont's 13F filing for Q3 2025, filed 14 Oct 2025.